Literature DB >> 34800622

Woodchuck Hepatic Anatomy and Vascular Alterations Due to Hepatocellular Carcinoma with Angiographic Atlas of the Abdomen and Pelvis.

Michal Mauda-Havakuk1, Michael T Kassin2, Andrew S Mikhail2, Juan A Esparza-Trujillo2, Ivane Bakhutashvili2, David L Woods2, Paul G Wakim3, Matthew F Starost4, John W Karanian2, Bradford J Wood5, William F Pritchard6.   

Abstract

PURPOSE: To characterize the hepatic and abdominal angiographic anatomy of woodchucks and vascular changes associated with hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Twenty-nine woodchucks (23 with viral-associated HCC, 6 without) underwent multiphasic computed tomography (CT). Fourteen woodchucks (8 with HCC) also underwent diagnostic angiography. Hepatic arterial diameters were measured on the CT scans. Woodchucks were divided into 3 groups: non-tumor-bearing, largest tumor supplied by the right hepatic artery (RHA), and largest tumor supplied by the left hepatic artery (LHA). Statistical analysis with a repeated measures model was performed to determine the effects of tumor location (right, left), vessel measured (RHA, LHA), and interaction between the 2 on vessel diameter. Lobar arteries supplying HCC were compared with those that did not.
RESULTS: CT anatomy and normal and variant vascular anatomy were defined. In woodchucks with HCC, LHA and RHA supplying tumors had mean diameters of 2.0 mm ± 0.3 and 1.6 mm ± 0.3 versus 1.5 mm ± 0.3 and 1.1 mm ± 0.2 for non-tumor-supplying arteries (P = .0002 and P < .0001), respectively. Lobar arteries supplying tumors were similarly ectatic. The right lateral lobe artery had the most profound increase in the mean diameter when supplying tumors, measuring 1.7 mm ± 0.1 versus 1.0 mm ± 0.1 in the non-tumor-supplying artery (P < .0001). There were no differences in the diameters of the aorta and celiac, common, and proper hepatic arteries between tumor- and non-tumor-bearing woodchucks. An angiographic atlas of the abdominal vessels was generated.
CONCLUSIONS: HCC tumoral vasculature in woodchucks was ectatic compared with normal vasculature. This phenomenon recapitulates human HCC and may facilitate investigation of transcatheter and drug delivery therapies in an HCC animal model. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34800622      PMCID: PMC8885882          DOI: 10.1016/j.jvir.2021.11.005

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  27 in total

1.  Development of an animal model for radiofrequency ablation of primary, virally induced hepatocellular carcinoma in the woodchuck.

Authors:  Charles T Burke; John M Cullen; Andrei State; Sashi Gadi; Kathy Wilber; Michael Rosenthal; Anna Bulysheva; Anthony Pease; Mathew A Mauro; Henry Fuchs
Journal:  J Vasc Interv Radiol       Date:  2011-09-29       Impact factor: 3.464

2.  Woodchuck VEGF (wVEGF) characteristics: Model for angiogenesis and human hepatocellular carcinoma directed therapies.

Authors:  Huayi Huang; Oreste Salavaggione; Lee Rivera; Sarbajit Mukherjee; Rolf Brekken; Bud Tennant; Renuka Iyer; Araba Adjei
Journal:  Arch Biochem Biophys       Date:  2018-11-13       Impact factor: 4.013

3.  Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma.

Authors:  William F Pritchard; David L Woods; Juan A Esparza-Trujillo; Matthew F Starost; Michal Mauda-Havakuk; Andrew S Mikhail; Ivane Bakhutashvili; Shelby Leonard; Elizabeth C Jones; Venkatesh Krishnasamy; John W Karanian; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2020-02-24       Impact factor: 3.464

4.  Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A VX2 Tumor Model Study.

Authors:  In Joon Lee; Myungsu Lee; Soo Jin Kim; You Kyung Kim; Jong Yun Won; Jin Wook Chung
Journal:  J Vasc Interv Radiol       Date:  2018-06-15       Impact factor: 3.464

5.  An immunohistochemical and ultrastructural study of the sinusoids of hepatocellular carcinoma.

Authors:  J Haratake; P J Scheuer
Journal:  Cancer       Date:  1990-05-01       Impact factor: 6.860

6.  Rabbit hepatic arterial anatomy variations: implications on experimental design.

Authors:  Alda L Tam; Marites P Melancon; Joe Ensor; Yang Liu; Katherine Dixon; Amanda McWatters; Sanjay Gupta
Journal:  Acta Radiol       Date:  2013-11-29       Impact factor: 1.990

7.  Transarterial Embolization of Liver Cancer in a Transgenic Pig Model.

Authors:  Fuad Nurili; Sebastien Monette; Adam O Michel; Achiude Bendet; Olca Basturk; Gokce Askan; Christopher Cheleuitte-Nieves; Hooman Yarmohammadi; Aaron W P Maxwell; Etay Ziv; Kyle M Schachtschneider; Ron C Gaba; Lawrence B Schook; Stephen B Solomon; F Edward Boas
Journal:  J Vasc Interv Radiol       Date:  2021-01-23       Impact factor: 3.464

8.  Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Lore Gruenbaum; Hans Bitter; Erik Rasmussen; Palanikumar Ravindran; David C Swinney; Fabian Birzele; Roland Schmucki; Stefan H Lorenz; Erhard Kopetzki; Jade Carter; Miriam Triyatni; Linta M Thampi; Junming Yang; Dalal AlDeghaither; Marta G Murreddu; Marta G Murredu; Paul Cote; Stephan Menne
Journal:  PLoS Pathog       Date:  2015-09-09       Impact factor: 6.823

9.  Suitability of the woodchuck HCC as a preclinical model for evaluation of intra-arterial therapies.

Authors:  Alexander Y Kim; Joseph H Yacoub; David H Field; Byoung Uk Park; Bhaskar Kallakury; Kyle E Korolowicz; Stephan Menne
Journal:  Animal Model Exp Med       Date:  2020-02-09

10.  Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model.

Authors:  Michal Mauda-Havakuk; Andrew S Mikhail; Matthew F Starost; Elizabeth C Jones; Baktiar Karim; David E Kleiner; Ari Partanen; Juan A Esparza-Trujillo; Ivane Bakhutashvili; Paul G Wakim; Michael T Kassin; Andrew L Lewis; John W Karanian; Bradford J Wood; William F Pritchard
Journal:  J Hepatocell Carcinoma       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.